NUEDEXTA (Avanir Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the NUEDEXTA drug offered from Avanir Pharmaceuticals, Inc.. This Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avanir Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | dextromethorphan hydrobromide and quinidine sulfate |
SUBSTANCE NAME: | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, GELATIN COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
NUEDEXTA HUMAN PRESCRIPTION DRUG Details:
Item Description | NUEDEXTA from Avanir Pharmaceuticals, Inc. |
LABELER NAME: | Avanir Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 10(mg/1; mg/1) |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64597-301_1231729d-b4fe-4b91-a82d-c0d27b460262 |
PRODUCT NDC: | 64597-301 |
APPLICATION NUMBER: | NDA021879 |
Other DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE Pharmaceutical Manufacturers / Labelers: